Unicycive Therapeutics, Inc.
NASDAQ:UNCY
0.4347 (USD) • At close October 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 9.701 | 0.455 | 16.579 | 0 | 0.015 | 0.025 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 9.701 | 0.455 | 16.579 | 0 | 0.015 | 0.025 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 3.698 | 2.189 | 1.832 | 0.004 | 0.004 | 0.004 |
| Total Current Assets
| 13.399 | 2.644 | 18.411 | 0.204 | 0.019 | 0.029 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 0.792 | 0.174 | 0.333 | 0 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | -0.174 | -0.333 | 0.2 | 0 | 0 |
| Total Non-Current Assets
| 0.792 | 0.174 | 0.333 | 0.2 | 0 | 0 |
| Total Assets
| 14.191 | 2.818 | 18.744 | 0.204 | 0.019 | 0.029 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 0.821 | 0.892 | 0.742 | 0.184 | 0.322 | 0.06 |
| Short Term Debt
| 0.345 | 0.155 | 0.151 | 2.514 | 0.46 | 1.047 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 16.368 | 2.237 | 1.212 | 0.177 | 0.121 | 0.128 |
| Total Current Liabilities
| 17.534 | 3.284 | 2.105 | 2.875 | 0.903 | 1.235 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0.466 | 0 | 0.155 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0.001 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 0.466 | 0.001 | 0.155 | 0 | 0 | 0 |
| Total Liabilities
| 18 | 3.284 | 2.26 | 2.875 | 0.903 | 1.235 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.035 | 0.015 | 0.015 | 0.009 | 0.008 | 0.034 |
| Retained Earnings
| -64.541 | -33.997 | -15.939 | -5.922 | -3.658 | -1.493 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 60.697 | 33.516 | 32.408 | 3.242 | 2.766 | 0.253 |
| Total Shareholders Equity
| -3.809 | -0.466 | 16.484 | -2.671 | -0.884 | -1.206 |
| Total Equity
| -3.809 | -0.466 | 16.484 | -2.671 | -0.884 | -1.206 |
| Total Liabilities & Shareholders Equity
| 14.191 | 2.818 | 18.744 | 0.204 | 0.019 | 0.029 |